193 related articles for article (PubMed ID: 34731783)
1. Serum procalcitonin and C-reactive protein levels as diagnostic markers for distinguishing bacterial infections from lupus flares in systemic lupus erythematosus: A systematic review and meta‑analysis.
Chen Y; Shen J; Yang H; Xu S; Ma Y; Pan F
Int Immunopharmacol; 2021 Dec; 101(Pt B):108304. PubMed ID: 34731783
[TBL] [Abstract][Full Text] [Related]
2. The role of MBL, PCT, CRP, neutrophil-lymphocyte ratio, and platelet lymphocyte ratio in differentiating infections from flares in lupus.
Musunuri B; Tripathy R; Padhi S; Panda AK; Das BK
Clin Rheumatol; 2022 Nov; 41(11):3337-3344. PubMed ID: 35835900
[TBL] [Abstract][Full Text] [Related]
3. The diagnostic values of C-reactive protein and procalcitonin in identifying systemic lupus erythematosus infection and disease activity.
Wang J; Niu R; Jiang L; Wang Y; Shao X; Wu M; Ma Y
Medicine (Baltimore); 2019 Aug; 98(33):e16798. PubMed ID: 31415387
[TBL] [Abstract][Full Text] [Related]
4. Serum procalcitonin has negative predictive value for bacterial infection in active systemic lupus erythematosus.
Bador KM; Intan S; Hussin S; Gafor AH
Lupus; 2012 Oct; 21(11):1172-7. PubMed ID: 22652631
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of serum presepsin, procalcitonin, copeptin, and high-sensitivity C-reactive protein for differentiating bacterial infection from disease activity in Egyptian patients with systemic lupus erythematosus.
AlJarhi UM; Sadek KM; Darwish EM; Elmessiery RM; Salem K; Khalil SA; Seif El Nasr SM; Kamel MF; Hesham D; Fayed A
Clin Rheumatol; 2021 May; 40(5):1861-1869. PubMed ID: 33111183
[TBL] [Abstract][Full Text] [Related]
6. Procalcitonin and C-reactive protein as markers of infection in systemic lupus erythematosus: the controversy continues.
El-Serougy E; Zayed HS; Ibrahim NM; Maged LA
Lupus; 2019 Oct; 28(11):1329-1336. PubMed ID: 29779437
[TBL] [Abstract][Full Text] [Related]
7. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.
Yu J; Xu B; Huang Y; Zhao J; Wang S; Wang H; Yang N
Mod Rheumatol; 2014 May; 24(3):457-63. PubMed ID: 24252006
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of procalcitonin for bacterial infections in patients undergoing hemodialysis: a systematic review and meta-analysis.
Tao M; Zheng D; Liang X; He Q; Zhang W
Ren Fail; 2022 Dec; 44(1):81-93. PubMed ID: 35164633
[TBL] [Abstract][Full Text] [Related]
9. Levels of serum procalcitonin and C-reactive protein for evaluating pulmonary bacterial infection in patients with lupus erythematosus.
Gao J; Zhang L; Zhang X; Zhao SL; Liu SY; Xing LH
J Huazhong Univ Sci Technolog Med Sci; 2016 Oct; 36(5):653-658. PubMed ID: 27752903
[TBL] [Abstract][Full Text] [Related]
10. Application of procalcitonin, white blood cell count and neutrophil-to-lymphocyte ratio in the diagnosis of systemic lupus erythematosus with a bacterial infection.
Li Z; Xiao Y; Zhang L
Ann Palliat Med; 2020 Nov; 9(6):3870-3876. PubMed ID: 33183029
[TBL] [Abstract][Full Text] [Related]
11. Development of Prediction Models for New Integrated Models and a Bioscore System to Identify Bacterial Infections in Systemic Lupus Erythematosus.
Zhai X; Feng M; Guo H; Liang Z; Wang Y; Qin Y; Wu Y; Zhao X; Gao C; Luo J
Front Cell Infect Microbiol; 2021; 11():620372. PubMed ID: 33732661
[TBL] [Abstract][Full Text] [Related]
12. Comparison of plasma/serum levels of procalcitonin between infection and febrile disease flare in patients with systemic lupus erythematosus: a meta-analysis.
Liu LN; Wang P; Guan SY; Li XM; Li BZ; Leng RX; Pan HF
Rheumatol Int; 2017 Dec; 37(12):1991-1998. PubMed ID: 28975431
[TBL] [Abstract][Full Text] [Related]
13. The combination of procalcitonin and C-reactive protein or presepsin alone improves the accuracy of diagnosis of neonatal sepsis: a meta-analysis and systematic review.
Ruan L; Chen GY; Liu Z; Zhao Y; Xu GY; Li SF; Li CN; Chen LS; Tao Z
Crit Care; 2018 Nov; 22(1):316. PubMed ID: 30463590
[TBL] [Abstract][Full Text] [Related]
14. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus.
Quintana G; Medina YF; Rojas C; Fernandez A; Restrepo JF; Rondon F; Iglesias A
J Clin Rheumatol; 2008 Jun; 14(3):138-42. PubMed ID: 18525431
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein is a more sensitive and specific marker for diagnosing bacterial infections in systemic lupus erythematosus compared to S100A8/A9 and procalcitonin.
Kim HA; Jeon JY; An JM; Koh BR; Suh CH
J Rheumatol; 2012 Apr; 39(4):728-34. PubMed ID: 22337236
[TBL] [Abstract][Full Text] [Related]
16. Serum procalcitonin and C-reactive protein levels as markers of bacterial infection in patients with liver cirrhosis: a systematic review and meta-analysis.
Lin KH; Wang FL; Wu MS; Jiang BY; Kao WL; Chao HY; Wu JY; Lee CC
Diagn Microbiol Infect Dis; 2014 Sep; 80(1):72-8. PubMed ID: 24974271
[TBL] [Abstract][Full Text] [Related]
17. Peripheral neutrophil CD64 index combined with complement, CRP, WBC count and B cells improves the ability of diagnosing bacterial infection in SLE.
Feng M; Zhang SL; Liang ZJ; Wang YL; Zhao XC; Gao C; Guo H; Luo J
Lupus; 2019 Mar; 28(3):304-316. PubMed ID: 30712491
[TBL] [Abstract][Full Text] [Related]
18. Serum procalcitonin for differentiating bacterial infection from disease flares in patients with autoimmune diseases.
Joo K; Park W; Lim MJ; Kwon SR; Yoon J
J Korean Med Sci; 2011 Sep; 26(9):1147-51. PubMed ID: 21935268
[TBL] [Abstract][Full Text] [Related]
19. Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus.
Lanoix JP; Bourgeois AM; Schmidt J; Desblache J; Salle V; Smail A; Mazière JC; Betsou F; Choukroun G; Duhaut P; Ducroix JP
Lupus; 2011 Feb; 20(2):125-30. PubMed ID: 20937623
[TBL] [Abstract][Full Text] [Related]
20. Combining Calcitonin and Procalcitonin and Rheumatoid Arthritis-Related Biomarkers Improve Diagnostic Outcomes in Early Rheumatoid Arthritis.
Liu Y; Shi J; Wang B; Zhou L; Zhou X; Du Y; Li D; Duan L; Hu Q; Chen W; Li P
Dis Markers; 2021; 2021():6331994. PubMed ID: 34136020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
